226 related articles for article (PubMed ID: 38016947)
1. Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2.
Vacondio D; Nogueira Pinto H; Coenen L; Mulder IA; Fontijn R; van Het Hof B; Fung WK; Jongejan A; Kooij G; Zelcer N; Rozemuller AJ; de Vries HE; de Wit NM
Cell Death Dis; 2023 Nov; 14(11):781. PubMed ID: 38016947
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy.
Carrano A; Hoozemans JJ; van der Vies SM; van Horssen J; de Vries HE; Rozemuller AJ
Neurodegener Dis; 2012; 10(1-4):329-31. PubMed ID: 22301467
[TBL] [Abstract][Full Text] [Related]
3. Liver X Receptor Alpha Is Important in Maintaining Blood-Brain Barrier Function.
Wouters E; de Wit NM; Vanmol J; van der Pol SMA; van Het Hof B; Sommer D; Loix M; Geerts D; Gustafsson JA; Steffensen KR; Vanmierlo T; Bogie JFJ; Hendriks JJA; de Vries HE
Front Immunol; 2019; 10():1811. PubMed ID: 31417573
[TBL] [Abstract][Full Text] [Related]
4. Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.
Carrano A; Hoozemans JJ; van der Vies SM; Rozemuller AJ; van Horssen J; de Vries HE
Antioxid Redox Signal; 2011 Sep; 15(5):1167-78. PubMed ID: 21294650
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
6. Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.
de Wit NM; Snkhchyan H; den Hoedt S; Wattimena D; de Vos R; Mulder MT; Walter J; Martinez-Martinez P; Hoozemans JJ; Rozemuller AJ; de Vries HE
J Alzheimers Dis; 2017; 60(3):795-807. PubMed ID: 27662305
[TBL] [Abstract][Full Text] [Related]
7. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
10. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction.
Gireud-Goss M; Mack AF; McCullough LD; Urayama A
Neuroscientist; 2021 Dec; 27(6):668-684. PubMed ID: 33238806
[TBL] [Abstract][Full Text] [Related]
12. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
13. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.
Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE
Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987
[TBL] [Abstract][Full Text] [Related]
14. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
15. Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology.
Attems J; Yamaguchi H; Saido TC; Thal DR
J Neurol Sci; 2010 Dec; 299(1-2):155-62. PubMed ID: 20850138
[TBL] [Abstract][Full Text] [Related]
16. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
17. TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model.
Versele R; Sevin E; Gosselet F; Fenart L; Candela P
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142143
[TBL] [Abstract][Full Text] [Related]
18. From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation.
Goulay R; Mena Romo L; Hol EM; Dijkhuizen RM
Transl Stroke Res; 2020 Aug; 11(4):601-614. PubMed ID: 31776837
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine potentiates amyloid
Carey A; Parodi-Rullan R; Vazquez-Torres R; Canepa E; Fossati S
Aging Cell; 2024 May; 23(5):e14106. PubMed ID: 38358083
[TBL] [Abstract][Full Text] [Related]
20. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
